| July 22, 2013
GlaxoSmithKline faces charges in China
Some GSK exectuives appear to have broken Chinese law. There's a battle going on between the Chinese government and Glaxosmithkline, and it may be spurred by high drug prices, reports CNBC's Eunice Yoon.
Sorry, we do not have a transcript available for this video at this time.